Researchers repurpose drug to deny drug-resistant fungus of iron, an element crucial to its survival
How do you fight a fungal infection that is becoming increasingly resistant to medicine? By starving it, found a team of University at Buffalo and Temple University researchers.
To treat Candida albicans, a common yeast that can cause illness in those with weakened immune systems, researchers limited the fungus’ access to iron, an element crucial to the organism’s survival.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy.”Mira Edgerton, research professor in the Department of Oral Biology at the UB School of Dental Medicine
They did so by using deferasirox, a medication used to treat blood disorders. Tested in mice, the results were promising: investigators decreased iron levels in saliva by four times, which altered the expression of more than 100 genes by the fungus, diminished its ability to infect oral mucosal tissue and caused a two-fold reduction in the organism’s survival rate.
“In the absence of novel drug candidates, drug repurposing aimed at using existing drugs to treat diseases is a promising strategy,” says Mira Edgerton, DDS, PhD, co-lead investigator of the study and research professor in the Department of Oral Biology at the UB School of Dental Medicine.
Edgerton, along with Sumant Puri, PhD, co-lead investigator and assistant professor in the Kornberg School of Dentistry at Temple University, published the study in March in Antimicrobial Agents and Chemotherapy.
Currently, only three major classes of clinical antifungal drugs exist. However, fungal drug resistance has steadily increased and no new classes of antifungals have emerged in decades, says Edgerton.
Candida albicans, a fungus among the group building resistance, is the agent behind a number of infections. They include oral thrush, a yeast infection in the mouth identified by a white film that coats the tongue and throat, causing painful swallowing; and denture-related stomatitis, a fungal infection that affects nearly two-thirds of U.S. denture wearers that causes inflammation, redness and swelling in the mouth.
The yeast is also the fourth leading cause of hospital-acquired bloodstream infections, which often have high mortality rates, says Edgerton.
Candida albicans is the most abundant fungus in the oral microbiome and relies heavily on saliva as a source for essential elements. Iron, the second most abundant metal in saliva, is a critical nutrient used by the fungus in several cellular processes, including energy production and DNA repair.
In mice, the group added deferasirox to drinking water to lower iron levels in saliva and reduce the availability of iron needed to sustain an infection.
The investigators found that Candida albicans in the mice who received the treatment were less likely to survive attacks by the immune system, subsisting at a 12 percent survival rate compared to a 25 percent survival rate in mice who did not receive the treatment.
The therapy also altered the expression of 106 genes by the fungus, a quarter of which were involved in the regulation of iron metabolism, directly regulated by iron or had iron-related functions. The study is the first report of iron starvation affecting gene expression of Candida albicans in real time during live infection, says Puri.
Other research has shown that treatment with deferasirox does not result in iron deficiency in adults with normal iron levels, forming the potential for preventative treatment for those who are also vulnerable to mucosal infections, says Puri.
The Latest on: Drug-resistant fungal infections
via Google News
The Latest on: Drug-resistant fungal infections
- People with low immunity prone to invasive fungal infections: Halluron August 22, 2021 at 7:30 pm
Dr Vinaykumar Hallur, a mycologist from the All India Institute of Medical Sciences (AIIMS), Bhubaneswar, along with his team, is credited to have discovered a new species of fungus, Cunninghamella ...
- New nanobiotechnology shows remarkable ability to battle dangerous fungal infectionson August 16, 2021 at 11:19 pm
They’re roughly the same size as a coronavirus particle, and 1000 times smaller than a human hair, yet newly engineered nanoparticles developed by scientists at the University of South Australia, are ...
- Fighting fungal infections: Giant leaps for smart nanobiotechnologyon August 16, 2021 at 6:54 am
They're roughly the same size as a coronavirus particle, and 1000 times smaller than a human hair, yet newly engineered nanoparticles are punching well above their weight when it comes to treating ...
- Fighting fungal infections: Giant leaps for smart nanotechon August 16, 2021 at 4:59 am
They're roughly the same size as a coronavirus particle, and 1000 times smaller than a human hair, yet newly engineered nanoparticles developed by scientists at the University of South Australia, are ...
- Nigeria: Fungus in Nigeria's Industrial Waste Produces a Promising Antibiotic Compoundon August 12, 2021 at 9:33 pm
Analysis - Antibiotics are life-saving drugs produced primarily by microorganisms which have been found in a variety of environments.
- Pan-resistant fungus identified in Texas, Washington, D.C. | Ask the Doctorson August 12, 2021 at 12:00 pm
I just saw on the TV news that there's a new fungus killing people in Texas, and that there's no cure for it. They're calling it a superbug, ...
- Fungus in Nigeria's industrial waste produces a promising antibiotic compoundon August 12, 2021 at 11:47 am
Read more: The world needs 'antibiotic guardians' to safeguard their future use Whether in hospitals or veterinary services, there are also increasing cases of drug resistance in Nigeria ... on human ...
- SCYNEXIS and Amplity Health Announce Agreement to…on August 11, 2021 at 3:54 am
Synergistic combination of Amplity’s proven commercial sales capabilities and SCYNEXIS’ internal medical, marketing, and strategic expertise will maximize Brexafemme’s commercial potential while ...
- CDC Reports Several Cases of Drug-Resistant Fungal Infection in Two U.S. Citieson August 5, 2021 at 10:15 pm
Three classes of antifungal drugs used for treating Candida infections include azoles, polyenes, and echinocandins. Eighty-five percent of C. auris cases detected are resistant to azoles ...
- Untreatable, Drug-Resistant Fungus Found in Texas and Washington, DCon July 29, 2021 at 5:00 pm
Because these pan-resistant infections occurred without any exposure to antifungal drugs, the cases are even more worrisome. These clusters are the first time such nosocomial transmission has been ...
via Bing News